Data2Discovery enables companies to transform to a new, innovative model for using data in AI-driven drug discovery. We leverage Artificial Intelligence and Machine Learning technologies along with very large sets of linked heterogeneous data, both public and proprietary, to pioneer entirely new ways of discovering and evaluating promising drug leads.
WuXi NextCODE is a life sciences company building the global standard platform for genomic data. With offices in Shanghai; Dublin; Kendall Square in Cambridge, Massachusetts; and Reykjavik, Iceland, we serve the leading population genomics, precision medicine, diagnostics, and wellness enterprises using the genome to improve health around the world. Our capabilities span cohort sourcing, study design, sequencing, scalable analytics including secondary and tertiary analysis, data storage, and AI and deep learning. Visit us at wuxinextcode.com.
At Accutar Biology, our mission is to employ Artificial Intelligence to help revolutionize drug discovery. By using our unique data-driven principle to explain the complex physical and chemical nature of biological system, we have created state-of-the-art proprietary Accutar computational platforms to improve efficiencies along each step of preclinical drug discovery, including hit identification, lead optimization, ADME prediction, chemical synthesis design and biological target prediction from small molecules. We also provide additional AI solutions upon customers’ requests.
BioSymetrics empowers pharmaceutical R&D innovation with leading data science expertise. Founded in 2015, BioSymetrics continues to make considerable investment developing Augusta™, an advanced SaaS-based biomedical Machine Learning (ML) platform. Augusta™ applies a first-of-its-kind “contingent AI” by combining ML and data pre-processing/integration in an iterative framework. The result? A proven increase of speed to market through all stages of drug discovery and research.
Numerate has mastered the conflicting demands of complex signal processing by applying advanced, proprietary AI, evolved to use all available data – literally everything the industry currently knows, against multiple, simultaneous drug design objectives. We model real biology and apply our models at a massive scale, sifting through noise to follow signals that elude other approaches.
V-Soft Labs is an advanced technology solutions provider with strategic locations throughout North America and India. The company delivers innovative solutions centered around Artificial Intelligence (AI) and Internet of Things (IoT) to help their clients lead their industries. This combined with enterprise-level development expertise is the reason V-Soft is trusted by leading companies across North America since 1997.